Clinical research staff
Annemieke Cats
Christianne Lok
Daan van den Broek
Floris Pos
Frans Opdam
Gabe Sonke
Hans Trum
Koert Kuhlmann
Marloes van Dongen
Michiel van den Brekel
Neeltje Steeghs
Rick Haas
Ritse Mann
Sabine Linn
Wouter Vogel
The Netherlands Cancer Institute is a comprehensive cancer center in which clinical research forms a vital bridge between discovery and patient care. By connecting basic, translational and clinical research, we help move new insights closer to meaningful impact for patients.
Around 25% of our patients take part in clinical trials. Most of these studies are investigator-initiated, reflecting the strong link between scientific curiosity, clinical questions and innovation at the NKI. We also collaborate closely with centres around the world to advance research and improve care.
Our institute has particular expertise in innovative Phase I/II trials, often developed in close collaboration with our basic and translational research groups. Over the years, we have also built extensive resources to support this work, including a large repository of patient data and a broad collection of tumour and healthy tissue.
Patient Impact Award
The Patient Impact Award is the Netherlands Cancer Institute’s annual award for clinical innovations that are expected to lead to, or have already led to, the improvement of diagnostics, survivorship, and/or treatment of patients with cancer.
This website uses cookies to ensure you get the best experience on our website.